About James Hsu
James Hsu joined DKSH in 2019 as Business Development, DKSH Technology. In this role, he is responsible for growing the life sciences and scientific instrumentations business. His previous experience was accumulated in the bustling Asian genomics and proteomics sector, where he worked on bringing a digital PCR startup to market. James graduated from the University of California, San Diego.
Articles by James Hsu
- How PROTACs Can Help Eradicate Cancer With Our Body’s Own Recycling System
- Bispecific Antibodies and Antibody Drug Conjugates: More Complex and Targeted Biologic Therapeutics
- How to evaluate lyophilization for molecular reagents and assay products?
- Understanding Asia’s growing role in epidermal growth factor receptor (EGFR) research
- Cell and gene therapy development: four Asian markets to look out for
- Trends in Personalized Cancer Diagnostics with Highly Sensitive Digital PCR
- How Fluorescence Flow Cytometry Is Helping to Elevate Extracellular Vesicles Analysis